4//SEC Filing
Marshman Fund Trust II 4
Accession 0000899243-20-023396
CIK 0001802665other
Filed
Aug 24, 8:00 PM ET
Accepted
Aug 25, 7:43 PM ET
Size
7.4 KB
Accession
0000899243-20-023396
Insider Transaction Report
Form 4
Marshman Fund Trust II
10% Owner
Transactions
- Conversion
Series A Preferred Stock
2020-08-21−25,983,571→ 0 total→ Common Stock (4,026,784 underlying) - Conversion
Common Stock
2020-08-21+4,026,784→ 10,958,547 total
Footnotes (2)
- [F1]Each share of preffered stock automatically converted on a 8.215-for-1 basis into common stock upon the closing of the Issuer's initial public offering.
- [F2]Includes 983,571 shares received upon the payment of an in-kind dividend on the Series A Preferred Stock on August 21, 2020.
Documents
Issuer
Harmony Biosciences Holdings, Inc.
CIK 0001802665
Entity typeother
IncorporatedIL
Related Parties
1- filerCIK 0001821461
Filing Metadata
- Form type
- 4
- Filed
- Aug 24, 8:00 PM ET
- Accepted
- Aug 25, 7:43 PM ET
- Size
- 7.4 KB